Moss Genomics Inc.

C$0.01As of Sun 8 Nov 2026, 12:00 UTC

CSE:MOSSHealthcare

Country Canada

PE (Fwd) —

TSR 4Y CAGR (59.02%)

Div yield —

ROE (72.77%)

Health Information Services

Beta (5Y) —

PE TTM —

TSR TTM (90.00%)

Mkt cap C$0.634M

ROIC (21.57%)

SE Grade™

—

Value

—

Quality

Moat

1Y Price

Reference

$0.0108

—

7.80%

—

TTM

FYE 30 Jun CAD

FY2022

FY2023

FY2024

FY2025

FY2026E

FY2027E

Trend

10Y

Peers

◌—

Revenue$M

—

◌—

—

Revenue growth%

—

Gross margin%

—

Operating margin%

—

Net margin%

—

P/E ratio (avg)x

—

EV/EBITx

—

(20.31)

FCF yield (avg)%

—

(6.80)

(1.16)

(3.25)

—

(3.25)

—

FCF margin%

—

0.153

FCF / Net incomex

—

0.944

0.979

0.269

0.460

—

0.702

—

(21.57)

ROIC%

—

(4502.33)

(1316.94)

(98.80)

—

(1316.94)

—

(72.77)

Return on equity%

—

(99.07)

(198.00)

(537.19)

(148.54)

—

(173.27)

—

(63.09)

Return on assets%

—

(81.74)

(576.10)

(183.10)

(56.53)

—

(132.42)

—

(0.01)

EPS$

—

(0.01)

(0.02)

—

(0.01)

—

EPS growth%

—

(11.66)

81.79

(355.46)

—

(11.66)

—

0.02

Bookvalue per sh$

—

0.01

—

0.02

8.35%

—

FCF per share$

—

(0.01)

(0.02)

—

(0.01)

—

Dividend per sh$

—

Div yield (avg)%

—

Payout ratio%

—

63.41

Shares (diluted)M

—

44.53

44.44

49.59

◌49.59

3.65%

—

Buyback yield%

—

0.19

—

(11.58)

◌—

—

D/E ratiox

—

0.580

Enterprise value$M

—

10.49

3.078

9.517

0.489

(4.76%)

—

LT debt$M

—

Peers (US$0.449M)

Cap (US$)

TripSitter Clinic Ltd.

0.895M

—

CareSpan Health, Inc.

0.674M

—

Kovo+ Holdings Inc.

0.636M

—

SCWorx Corp.

0.708M

—

Capital

TTM

10Y

Leveragex

—

EBIT/Intx

—

(335.5)

Own earn%

—

Sh yield%

—

Owners

Insiders/Inst%

19.33

—

Short interest%

—

SBC / revenue%

—

Record

10Y

Profitable years

0/4

Revenue growth years

—

EPS growth years

1/3

Dividend streakyrs

Op margin range%

—

$1 testx

—

Incr. ROIC%

Moss Genomics Inc. is a biotechnology company focused on genomics and microbiome research to develop advanced genetic insights and solutions in Canada. It offers encrypted vault, genetic insights, and monetize your data; and vault hosting, pay per genome, and proof of personhood. The company was formerly known as Nou Camp Capital Corp. and changed its name to Moss Genomics Inc. in July 2021. Moss Genomics Inc.

Revenue by segment

No breakdown available

Asset mix

Trend

Other

95.43%

Cash and investments

4.57%

Reinvestment returns

No breakdown available